Linda M. Henricks
Leiden University Medical Center(NL)Isala(NL)Amsterdam University Medical Centers(NL)University of Amsterdam(NL)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Biochemical and Molecular Research, Pancreatic and Hepatic Oncology Research, Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update(2017)633 cited
- → DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis(2018)407 cited
- → Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data(2015)368 cited
- → Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time(2015)140 cited
- → Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity(2017)119 cited
- → Translating DPYD Genotype into DPD Phenotype: Using the Gene Activity Score